Skip to content
MatchScript
Menu

Head-to-head · The Match Score

Vaylen vs Tablet Health

Both scored on the same six-factor Match Score. Vaylen wins this matchup with a 87 to 49 edge.

Higher Match Score

Vaylen

#8 · Grade B+

People who want maximum options — injectable, oral, compounded or brand — in one LegitScript-certified place.

Visit Vaylen
VS

Tablet Health

#461 · Grade C

People who want legitScript-certified GLP-1 with an oral option and named compounders.

Visit Tablet Health

Factor by factor

The six sub-scores behind each Match Score. The quiz reweights these to your priorities — one provider can pull ahead for you on the factors you care about.

Budget Fit
82
48
Speed to Start
88
43
Formulary Match
94
51
Support Level
86
55
Flexibility
86
55
Transparency
88
40

Price, coverage & formulary

DetailVaylenTablet Health
Semaglutide$179/moNot disclosed
Tirzepatide$239/moNot disclosed
CoverageAll 50 statesCoverage not published
Brand-name accessYesCompounded only
Oral / sublingualYesYes
Match Score87 · B+49 · C
Winner: Vaylen

Vaylen edges out Tablet Health, 87 to 49 on the default Match Score. One of the widest formularies on the board — both molecules, an oral route, and brand access, all nationwide.

Tablet Health is still a fair pick if its strengths line up with yours — best for: People who want legitScript-certified GLP-1 with an oral option and named compounders.

Worth a look either way: our overall #1 pick is CoreAge Rx (Match Score 91) — nationwide access, both molecules at one flat price, easy to cancel. Or take the 6-question quiz to see your personalized match.

Assume any provider we list may compensate us, at no cost to you. It never changes the Match Score.

Full Vaylen reviewFull Tablet Health review

More head-to-heads

Or browse alternatives to Vaylen and all comparisons.

Pricing, states and verification reflect each provider's public disclosures at last review; the Match Score and its sub-scores are our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.